Absorption |
Blood-Brain Barrier | BBB+ | 0.9846 |
Human Intestinal Absorption | HIA+ | 0.9971 |
Caco-2 Permeability | Caco2+ | 0.7441 |
P-glycoprotein Substrate | Non-substrate | 0.6965 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.9195 |
Non-inhibitor | 0.9736 |
Renal Organic Cation Transporter | Non-inhibitor | 0.7896 |
Distribution |
Subcellular localization | Lysosome | 0.6999 |
Metabolism |
CYP450 2C9 Substrate | Non-substrate | 0.8094 |
CYP450 2D6 Substrate | Non-substrate | 0.7986 |
CYP450 3A4 Substrate | Non-substrate | 0.6645 |
CYP450 1A2 Inhibitor | Inhibitor | 0.7955 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.8258 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.6158 |
CYP450 2C19 Inhibitor | Inhibitor | 0.8602 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.7629 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.7327 |
Excretion |
Toxicity |
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9637 |
Non-inhibitor | 0.8180 |
AMES Toxicity | AMES toxic | 0.9340 |
Carcinogens | Non-carcinogens | 0.9157 |
Fish Toxicity | High FHMT | 0.5680 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.9113 |
Honey Bee Toxicity | High HBT | 0.5675 |
Biodegradation | Not ready biodegradable | 0.8863 |
Acute Oral Toxicity | III | 0.6056 |
Carcinogenicity (Three-class) | Non-required | 0.6928 |